Gene Logic aims to be the drug development partner of choice for the pharmaceutical and biotechnology industries by providing a unique portfolio of drug discovery and development solutions. Our capabilities span the drug development pipeline and address some of the most important issues in drug development today - productivity, safety, and enhancing late-stage pipelines. Gene Logic two business units are:

• Drug Repositioning and Selection
• Genomics Services

Through our Drug Repositioning and Selection™ (DRS™) Program, Gene Logic provides the pharmaceutical industry a unique cost-effective, low-risk partnering solution for finding new uses for their discontinued compounds, prioritizing the most promising lead candidates and finding the broadest therapeutic applications for a marketed compound lifecycle. Our partnerships are flexible, full service collaborations providing pharmaceutical companies the ability to share risk while working together to achieve success. Partners receive full access to our dedicated team of industry-leading drug developers and our comprehensive, multi-prong drug repositioning and selection technology platform.

Pharmaceutical and biotechnology companies worldwide trust Gene Logic's proven portfolio of Genomics Services to help accelerate their drug development process. Utilizing our scientific expertise and genomics informatics capabilities, we have built a portfolio of gene reference and clinical database systems, software, toxicity consulting services, as well as gene expression and genotyping microarray data generation outsourcing services, designed to meet a variety of economic needs and support applications for:

• Microarray Reference Data Generation
• Gene Expression Profiling
• SNP Genotyping
• Data Analysis Services